Skip to main content

The Shoppers Drug Mart store located near the corner of College Street and Yonge Street in Toronto is photographed on April 13, 2017.

Fred Lum/The Globe and Mail

Medical marijuana producer MedReleaf says it has signed an agreement to become a medical cannabis supplier to Shoppers Drug Mart.

The company says it will supply Canada's largest pharmacy retailer with MedReleaf branded medical cannabis products, subject to Health Canada approving Shoppers Drug Mart's application to dispense medical marijuana.

MedReleaf says it expects that its products will be sold online, as Canadian regulations do not currently allow for the sale of medical cannabis in retail pharmacies.

Story continues below advertisement

This comes less than a month after licensed producer Aphria signed a five-year agreement to supply Shoppers with its branded medical cannabis, including four strains of dried marijuana flower and four cannabis oils.

The pharmacy chain's parent company Loblaw Companies Ltd. applied for a license to dispense medical marijuana in Oct. 2016.

Loblaw has said it believes pharmacists and pharmacies have a role to play in the distribution of medical cannabis, and Shoppers posted a job ad for a medical marijuana brand manager last month.

Andrew Willis of Report on Business tells investors why they should be wary of buying into private pot businesses going public The Globe and Mail
Report an error
Tickers mentioned in this story
Unchecking box will stop auto data updates
Comments are closed

We have closed comments on this story for legal reasons or for abuse. For more information on our commenting policies and how our community-based moderation works, please read our Community Guidelines and our Terms and Conditions.

Due to technical reasons, we have temporarily removed commenting from our articles. We hope to have this fixed soon. Thank you for your patience. If you are looking to give feedback on our new site, please send it along to feedback@globeandmail.com. If you want to write a letter to the editor, please forward to letters@globeandmail.com.